LABCORP HOLDINGS INC.
LH
78 insider filings · Latest: Aug 11, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2026 | Aug 12 6:31 PM | Adam H SchechterDirector, President & CEO | Sale | 4,669 | $320.37 | $1.5M | 102,565(D) | View → |
| Aug 11, 2026 | Aug 11 2:06 PM | Schechter Adam H | Proposed Sale | 4,669 | $320.37 | $1.5M | — | View → |
| Aug 4, 2026 | Aug 6 12:26 PM | Amy B. SummyEVP, Chief Marketing Officer | Sale | 924 | $306.74 | $283.4K | 6,955.5(D) | View → |
| Aug 3, 2026 | Aug 5 3:17 PM | Peter J WilkinsonSVP, Chief Accounting Officer | Sale | 1,420 | $309.23 | $439.1K | 1,770.219(D) | View → |
| Aug 4, 2026 | Aug 4 3:58 PM | Summy Amy B. | Proposed Sale | 924 | $306.74 | $283.4K | — | View → |
| Jul 2, 2026 | Jul 6 1:37 PM | Kathryn W KyleEVP, Chief Legal Officer | Sale | 92 | $286.19 | $26.3K | 3,904.457(D) | View → |
| Jul 2, 2026 | Jul 6 1:36 PM | Bryan T VaughnEVP and President, Diagnostics | Sale | 234 | $286.19 | $67.0K | 6,745.57(D) | View → |
| Jul 2, 2026 | Jul 2 4:19 PM | Kyle Kathryn W | Proposed Sale | 92 | $286.19 | $26.3K | — | View → |
| Jul 2, 2026 | Jul 2 2:29 PM | Vaughn Bryan T | Proposed Sale | 234 | $286.19 | $67.0K | — | View → |
| Jul 1, 2026 | Jul 1 2:03 PM | van der Vaart Sandra D | Proposed Sale | 7,138 | $280.48 | $2.0M | — | View → |
| Jun 8, 2026 | Jun 10 1:01 PM | Kathryn W KyleEVP, Chief Legal Officer | Sale | 762 | $263.89 | $201.1K | 3,813.457(D) | View → |
| Jun 8, 2026 | Jun 8 4:19 PM | Kyle Kathryn W | Proposed Sale | 762 | $263.89 | $201.1K | — | View → |
| May 11, 2026 | May 13 1:30 PM | Adam H SchechterDirector, President & CEO | Sale | 5,903 | $254.50 | $1.5M | 107,234(D) | View → |
| May 11, 2026 | May 11 1:51 PM | Schechter Adam H | Proposed Sale | 5,903 | $254.50 | $1.5M | — | View → |
| May 6, 2026 | May 6 2:40 PM | van der Vaart Sandra D | Proposed Sale | 6,238 | $256.76 | $1.6M | — | View → |
| Mar 27, 2026 | Mar 30 4:54 PM | Peter J WilkinsonSVP, Chief Accounting Officer | Sale | 1,633 | $267.05 | $436.1K | 1,852.219(D) | View → |
| Mar 27, 2026 | Mar 30 4:44 PM | Jonathan C MeltzerEVP, Operations | Sale | 839 | $267.05 | $224.1K | 3,620.326(D) | View → |
| Mar 27, 2026 | Mar 27 2:40 PM | Meltzer Jonathan C | Proposed Sale | 839 | $267.05 | $224.1K | — | View → |
| Mar 3, 2026 | Mar 5 1:57 PM | Adam H SchechterDirector, President & CEO | Sale | 8,705 | $279.96 | $2.4M | 80,773(D) | View → |
| Mar 3, 2026 | Mar 3 5:23 PM | Schechter Adam H | Proposed Sale | 8,705 | $279.96 | $2.4M | — | View → |
Page 1 of 3
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 10, 2026 | Feb 12 4:05 PM | Peter M NeupertDirector | Grant/Award | 773 | — | 1,670(D) | View → |
| Feb 10, 2026 | Feb 12 4:03 PM | Kirsten Marie KliphouseDirector | Grant/Award | 773 | — | 1,670(D) | View → |
| Feb 10, 2026 | Feb 12 4:02 PM | Jeffrey A. DavisDirector | Grant/Award | 773 | — | 1,670(D) | View → |
| Feb 10, 2026 | Feb 12 4:00 PM | Carulla Victor BultoDirector | Grant/Award | 773 | — | 909(D) | View → |
| Feb 10, 2026 | Feb 12 3:59 PM | Kerrii B AndersonDirector | Grant/Award | 773 | — | 1,670(D) | View → |
| Feb 6, 2026 | Feb 10 8:34 PM | Julia Aijun WangChief Financial Officer, EVP | Option Exercise | 893 | — | 3,474(D) | View → |
| Feb 7, 2026 | Feb 10 8:18 PM | Brian J CaveneyEVP, Pres of ED, CMO & CSO | Option Exercise | 628 | — | 2,890(D) | View → |
| Feb 6, 2026 | Feb 10 8:18 PM | Brian J CaveneyEVP, Pres of ED, CMO & CSO | Option Exercise | 670 | — | 3,518(D) | View → |
| Feb 7, 2026 | Feb 10 8:15 PM | Akinbolade OyegunwaEVP, CIO & CTO | Option Exercise | 149 | — | 1,610(D) | View → |
| Feb 6, 2026 | Feb 10 8:15 PM | Akinbolade OyegunwaEVP, CIO & CTO | Option Exercise | 180 | — | 1,759(D) | View → |
| Feb 7, 2026 | Feb 10 8:13 PM | Adam H SchechterDirector, President & CEO | Option Exercise | 3,249 | — | 15,430(D) | View → |
| Feb 6, 2026 | Feb 10 8:13 PM | Adam H SchechterDirector, President & CEO | Option Exercise | 4,460 | — | 18,679(D) | View → |
| Feb 7, 2026 | Feb 10 8:08 PM | Peter J WilkinsonSVP, Chief Accounting Officer | Option Exercise | 134 | — | 2,224(D) | View → |
| Feb 6, 2026 | Feb 10 8:08 PM | Peter J WilkinsonSVP, Chief Accounting Officer | Option Exercise | 133 | — | 2,358(D) | View → |
| Feb 7, 2026 | Feb 10 8:07 PM | Mark S SchroederEVP, Pres Diagnostics & COO | Option Exercise | 681 | — | 3,164(D) | View → |
| Feb 6, 2026 | Feb 10 8:07 PM | Mark S SchroederEVP, Pres Diagnostics & COO | Option Exercise | 743 | — | 3,845(D) | View → |
| Feb 7, 2026 | Feb 10 8:06 PM | Der Vaart Sandra D VanEVP, Corporate Affairs | Option Exercise | 353 | — | 1,517(D) | View → |
| Feb 6, 2026 | Feb 10 8:06 PM | Der Vaart Sandra D VanEVP, Corporate Affairs | Option Exercise | 387 | — | 1,870(D) | View → |
| Feb 7, 2026 | Feb 10 8:05 PM | Bryan T VaughnEVP, Diagnostics | Option Exercise | 178 | — | 3,624(D) | View → |
| Feb 6, 2026 | Feb 10 8:05 PM | Bryan T VaughnEVP, Diagnostics | Option Exercise | 180 | — | 3,802(D) | View → |